Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2020 Filed Nov 24, 2020 23:49 UTC |
Rutz Michael PPresident of Sterigenics
|
GrantStock Options · Derivative | 111,801 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032067 · doc4.xml · derivative · entry 2 Rutz Michael P · CIK 0001599220 · President of Sterigenics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,801 Underlying: Common Stock · 111,801 shares Expires 2030-11-20 F3 · derivative.exercise_date: These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:49 UTC |
Rutz Michael PPresident of Sterigenics
|
GrantCommon Stock, $0.01 par value per share ("Common Stock") | 26,086 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032067 · doc4.xml · nonDerivative · entry 1 Rutz Michael P · CIK 0001599220 · President of Sterigenics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621,043 F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. F2 · balance_after: Consists of 26,086 RSUs and 594,957 shares of Common Stock. 16,199 of the shares of Common Stock are vested, and 578,758 of the shares of Common Stock remain subject to vesting conditions. 20% of the shares of Common Stock will vest on May 13, 2021 (the one year anniversary of the date of grant), and the remaining shares will vest on a daily basis, pro rata through May 13, 2025. See Footnote #1 for information regarding the vesting of the RSUs. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:45 UTC |
Chen RuoxiDirector
|
GrantCommon Stock, $0.01 par value per share ("Common Stock") | 5,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032060 · doc4.xml · nonDerivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,869 F1 · shares: These securities consist of 5,869 Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:48 UTC |
Klee Ann R.Director
|
GrantCommon Stock, $0.01 par value per share ("Common Stock") | 5,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032065 · doc4.xml · nonDerivative · entry 1 Klee Ann R. · CIK 0001796076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,794 F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: Consists of 5,869 RSUs and 50,925 shares of Common Stock, including 16,199 shares of vested Common Stock and 34,726 shares of unvested Common Stock. 20% of the unvested shares of Common Stock will vest on May 27, 2021 (the one year anniversary of the date of grant), and the remaining unvested shares will vest on a daily basis pro rata thereafter, through May 27, 2025. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:02 UTC |
Leffler Scott J.CFO and Treasurer
|
GrantStock Options · Derivative | 223,602 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032083 · doc4.xml · derivative · entry 3 Leffler Scott J. · CIK 0001832406 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,602 Underlying: Common Stock · 223,602 shares Expires 2030-11-20 F5 · derivative.exercise_date: These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:02 UTC |
Leffler Scott J.CFO and Treasurer
|
GrantCommon Stock, $0.01 par value per share ("Common Stock") | 52,173 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032083 · doc4.xml · nonDerivative · entry 1 Leffler Scott J. · CIK 0001832406 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 820,426 F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. F2 · balance_after: Consists of 768,253 shares of Common Stock (see Footnote #4 for information regarding the vesting of the Common Stock) and 52,173 RSUs. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:00 UTC |
CUNNINGHAM SEAN LAURENCEDirector
|
GrantCommon Stock, $0.01 par value per share ("Common Stock") | 5,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032082 · doc4.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,869 F1 · shares: These securities consist of 5,869 Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:56 UTC |
Petras Michael B. Jr.Director · Chairman & CEO
|
GrantStock Options · Derivative | 1,118,012 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032076 · doc4.xml · derivative · entry 4 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,118,012 Underlying: Common Stock · 1,118,012 shares Expires 2030-11-20 F3 · derivative.exercise_date: These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:56 UTC |
Petras Michael B. Jr.Director · Chairman & CEO
|
GrantCommon Stock, $0.01 par value per share ("Common Stock") | 260,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032076 · doc4.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,869 F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.